Metformin is best known as a diabetes medicine, the kind of familiar prescription that often sits quietly in a bathroom cabinet. But researchers are looking at a bigger question: could this old drug help with weight, hormone-related metabolic problems, and the heart?
The answer is promising, but not simple. Studies suggest possible benefits beyond blood sugar control, yet doctors still prescribe metformin mainly to improve glucose levels in people with type-2 diabetes.
The official U.S. Food and Drug Administration label describes metformin as an addition to diet and exercise for adults and children aged 10 and older with type-2 diabetes.
Why metformin matters
Metformin helps lower blood sugar partly by reducing how much sugar the liver releases and by helping the body respond better to insulin. Insulin is the hormone that moves sugar from the blood into cells, where it can be used for energy.
That basic role is still the foundation. The medication is not a substitute for food choices, movement, sleep, or medical monitoring, even when it is being studied for other uses.
Weight is the quieter question
Weight loss is one reason metformin keeps coming up in medical conversations. In the Diabetes Prevention Program Outcomes Study, the Diabetes Prevention Program Research Group found that 28.5% of participants taking metformin lost at least 5% of their body weight after one year.
That is not the same as calling metformin a weight-loss drug. The result was modest, and real life is messier than a study. What happens at breakfast, on a walk after school or work, and during months of follow-up still matters.
Doctors also sometimes use metformin to manage weight gain linked to antipsychotic medicines. A 2024 guideline found that starting metformin alongside antipsychotics reduced weight gain by about 8.9 lbs. compared with controls, but that use should be individualized.
PCOS and insulin resistance
Metformin is also discussed in care for polycystic ovary syndrome, known as PCOS. This condition can involve irregular periods, excess androgen hormones, acne, fertility problems, weight changes, and insulin resistance.
What is insulin resistance? In simple terms, the body hears insulin’s message poorly, so the pancreas has to work harder and blood sugar may rise. For some people with PCOS, improving that signal can help with metabolic health and, in certain cases, menstrual patterns.
A 2023 international guideline developed by Monash University’s Centre for Research Excellence in Women’s Health in Reproductive Life with several medical societies recommends metformin mainly for metabolic features of PCOS.
The same guidance notes that letrozole is the first-line drug for infertility related to lack of ovulation, with metformin playing a more limited or second-line role.
The heart question
The cardiovascular angle may be the most important for long-term health. Heart disease and stroke are major concerns for people with diabetes, so any medicine tied to lower cardiovascular risk deserves careful attention.
A review led by Yizhi Bu with researchers from Hunan Normal University and Shanghai Jiao Tong University reported that growing clinical and preclinical evidence links metformin with fewer cardiovascular events, even beyond its blood sugar effects.
In sum, researchers are asking whether the drug may help protect blood vessels and reduce stress and inflammation inside them.
Still, this is not a free pass. A person at risk for heart disease still needs blood pressure care, cholesterol management, smoking cessation when relevant, physical activity, and the usual unglamorous habits that keep showing up in medical advice.
Off-label does not mean automatic
The word “off-label” can sound suspicious, but it is common in medicine. It means a clinician uses an approved drug for a condition, dose, or group that is not listed on the official label, because they believe it may help that patient.
That does not mean the use is automatically proven. The FDA cautions that when an approved drug is used for an unapproved purpose, the agency has not determined that it is safe and effective for that specific use. That is why the conversation belongs in a clinic, not in a comment thread.
Metformin can also cause side effects, especially stomach-related ones such as diarrhea, nausea, and upset stomach. People with kidney problems, heavy alcohol use, certain acute illnesses, or other risk factors may need extra caution, and nobody should start, stop, or change a dose without a health professional.
What researchers are watching next
The next wave of metformin research is wider than diabetes. Scientists are studying whether it may influence inflammation, cellular stress, and the biology of aging, which is the slow wear and tear behind many chronic diseases.
The Targeting Aging with Metformin Trial, managed by the American Federation for Aging Research, is designed as a nationwide effort involving more than 3,000 adults ages 65 to 79 at 14 research sites.
The plan is to test whether metformin can delay the development or progression of age-related diseases such as heart disease, cancer, and dementia.
That sounds exciting, but it is also exactly where caution matters. Until stronger human evidence is available, metformin remains a proven diabetes drug with possible extra benefits, not a do-it-yourself longevity plan.
The main studies and official guidance behind this article have been published in Annals of Internal Medicine, the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, and the Journal of Cellular and Molecular Medicine.
